A Case of Refractory Oral Aphthous Ulcer Successfully Treated with Adalimumab
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김진영 | - |
dc.contributor.author | 송명진 | - |
dc.contributor.author | 정혜진 | - |
dc.contributor.author | 조수경 | - |
dc.contributor.author | 성윤경 | - |
dc.date.accessioned | 2021-07-30T05:12:12Z | - |
dc.date.available | 2021-07-30T05:12:12Z | - |
dc.date.created | 2021-05-13 | - |
dc.date.issued | 2017-06 | - |
dc.identifier.issn | 2093-940X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/3530 | - |
dc.description.abstract | Oral aphthous ulcer is a common lesion characterized by loss of dermal tissue of various shapes in many diseases. It is not serious, but may affect quality of life through pain and discomfort. In many cases, it heals spontaneously without treatment or with topical agents such as antiseptics, analgesics and corticosteroid in a few days. However, rarely, there are a few cases of aphthous ulcer that remain refractory despite appropriate treatment. Tumor necrosis factor-α inhibitors have recently been used in treatment of severe mucosal ulcer in Behçet’s disease. Herein, we report a patient suffering from refractory oral aphthous ulcers that were resistant to topical and systemic agents, but were successfully treated with adalimumab. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한류마티스학회 | - |
dc.title | A Case of Refractory Oral Aphthous Ulcer Successfully Treated with Adalimumab | - |
dc.title.alternative | A Case of Refractory Oral Aphthous Ulcer Successfully Treated with Adalimumab | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 조수경 | - |
dc.contributor.affiliatedAuthor | 성윤경 | - |
dc.identifier.doi | 10.4078/JRD.2017.24.3.157 | - |
dc.identifier.bibliographicCitation | 대한류마티스학회지, v.24, no.3, pp.157 - 160 | - |
dc.relation.isPartOf | 대한류마티스학회지 | - |
dc.citation.title | 대한류마티스학회지 | - |
dc.citation.volume | 24 | - |
dc.citation.number | 3 | - |
dc.citation.startPage | 157 | - |
dc.citation.endPage | 160 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART002235551 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordAuthor | Oral ulcer | - |
dc.subject.keywordAuthor | Aphthous stomatitis | - |
dc.subject.keywordAuthor | Tumor necrosis factor-alpha inhibitor | - |
dc.subject.keywordAuthor | Adalimumab | - |
dc.identifier.url | https://synapse.koreamed.org/articles/1064322 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.